{"id":"https://openalex.org/W2466833405","doi":null,"title":"Effekter p\u00e5 insulinsekresjon og endotelfunksjon av DPP-IV-hemmeren sitagliptin (Januvia\u00ae) hos pasienter som har utviklet diabetes etter nyretransplantasjon.","display_name":"Effekter p\u00e5 insulinsekresjon og endotelfunksjon av DPP-IV-hemmeren sitagliptin (Januvia\u00ae) hos pasienter som har utviklet diabetes etter nyretransplantasjon.","alternate_titles":[],"publication_year":2012,"publication_date":"2012-01-01","ids":{"openalex":"https://openalex.org/W2466833405","mag":"2466833405"},"language":"no","primary_location":{"id":"pmh:https://api.nva.unit.no/publication/019c8f5818f0-8d5906ee-4688-427d-ae80-9439d591c15a","doi":null,"is_oa":true,"landing_page_url":"https://hdl.handle.net/10852/12051","pdf_url":null,"source":{"id":"https://openalex.org/S7407153562","display_name":"NVA (Nasjonalt vitenarkiv)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/masterThesis"},"parent_works":[],"lineage":["https://openalex.org/W2466833405"],"child_works_count":0,"type":"dissertation","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://hdl.handle.net/10852/12051","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5074068104","display_name":"Thea Anine Str\u00f8m Halden","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I184942183","display_name":"University of Oslo","ror":"https://ror.org/01xtthb56","country_code":"NO","type":"education","lineage":["https://openalex.org/I184942183"]}],"countries":["NO"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Thea Anine Str\u00f8m Halden","raw_affiliation_strings":["Avdeling for farmas\u00f8ytisk biovitenskap, Farmas\u00f8ytisk institutt, Det matematisk-naturvitenskaplige fakultet, UNIVERSITETET I OSLO"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Avdeling for farmas\u00f8ytisk biovitenskap, Farmas\u00f8ytisk institutt, Det matematisk-naturvitenskaplige fakultet, UNIVERSITETET I OSLO","institution_ids":["https://openalex.org/I184942183"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5074068104"],"corresponding_institution_ids":["https://openalex.org/I184942183"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"reviewed_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9785000085830688,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9785000085830688,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.007199999876320362,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10373","display_name":"Renal Transplantation Outcomes and Treatments","score":0.005200000014156103,"subfield":{"id":"https://openalex.org/subfields/2747","display_name":"Transplantation"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sitagliptin","display_name":"sitagliptin","score":0.996999979019165},{"id":"https://openalex.org/keywords/dpp-4-inhibitors","display_name":"DPP-4 inhibitors","score":0.9819999933242798},{"id":"https://openalex.org/keywords/insulin-secretion","display_name":"insulin secretion","score":0.7839999794960022},{"id":"https://openalex.org/keywords/endothelial-function","display_name":"endothelial function","score":0.9580000042915344},{"id":"https://openalex.org/keywords/kidney-transplantation","display_name":"kidney transplantation","score":0.4429999887943268},{"id":"https://openalex.org/keywords/post-transplant-diabetes-mellitus","display_name":"post-transplant diabetes mellitus","score":0.753000020980835},{"id":"https://openalex.org/keywords/impaired-glucose-tolerance","display_name":"impaired glucose tolerance","score":0.7699999809265137},{"id":"https://openalex.org/keywords/glucagon-like-peptide-1","display_name":"glucagon-like peptide-1","score":0.7129999995231628},{"id":"https://openalex.org/keywords/glucose-dependent-insulinotropic-polypeptide","display_name":"glucose-dependent insulinotropic polypeptide","score":0.8980000019073486},{"id":"https://openalex.org/keywords/cardiovascular-risk","display_name":"cardiovascular risk","score":0.4729999899864197},{"id":"https://openalex.org/keywords/renal-function","display_name":"renal function","score":0.36399999260902405},{"id":"https://openalex.org/keywords/prednisolone","display_name":"prednisolone","score":0.7039999961853027},{"id":"https://openalex.org/keywords/inflammatory-markers","display_name":"inflammatory markers","score":0.3700000047683716},{"id":"https://openalex.org/keywords/endothelial-cell-adhesion-molecules","display_name":"endothelial adhesion molecules","score":0.3840000033378601},{"id":"https://openalex.org/keywords/nitric-oxide","display_name":"nitric oxide","score":0.3449999988079071},{"id":"https://openalex.org/keywords/nitric-oxide-synthase","display_name":"nitric oxide synthase","score":0.5180000066757202},{"id":"https://openalex.org/keywords/nitric-oxide-synthase-inhibition","display_name":"nitric oxide synthase inhibition","score":0.3799999952316284}],"concepts":[{"id":"https://openalex.org/C2779284873","wikidata":"https://www.wikidata.org/wiki/Q419832","display_name":"Sitagliptin","level":4,"score":0.9093409180641174},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5053804516792297},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.26342523097991943},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.23792415857315063},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.09728196263313293}],"mesh":[],"locations_count":3,"locations":[{"id":"pmh:https://api.nva.unit.no/publication/019c8f5818f0-8d5906ee-4688-427d-ae80-9439d591c15a","doi":null,"is_oa":true,"landing_page_url":"https://hdl.handle.net/10852/12051","pdf_url":null,"source":{"id":"https://openalex.org/S7407153562","display_name":"NVA (Nasjonalt vitenarkiv)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/masterThesis"},{"id":"pmh:oai:www.duo.uio.no:10852/12051","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/10852/12051","pdf_url":null,"source":{"id":"https://openalex.org/S7407064446","display_name":"NORA - Norwegian Open Research Archives","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/masterThesis"},{"id":"mag:2466833405","doi":null,"is_oa":false,"landing_page_url":"https://www.duo.uio.no/bitstream/10852/12051/4/Masteroppgave_Halden_Thea_Anine_Strom.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":{"id":"pmh:https://api.nva.unit.no/publication/019c8f5818f0-8d5906ee-4688-427d-ae80-9439d591c15a","doi":null,"is_oa":true,"landing_page_url":"https://hdl.handle.net/10852/12051","pdf_url":null,"source":{"id":"https://openalex.org/S7407153562","display_name":"NVA (Nasjonalt vitenarkiv)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/masterThesis"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2466833405.pdf","grobid_xml":"https://content.openalex.org/works/W2466833405.grobid-xml"},"referenced_works_count":89,"referenced_works":["https://openalex.org/W25954816","https://openalex.org/W130204912","https://openalex.org/W1533612626","https://openalex.org/W1545442421","https://openalex.org/W1545469792","https://openalex.org/W1547502182","https://openalex.org/W1550111394","https://openalex.org/W1575301182","https://openalex.org/W1966448013","https://openalex.org/W1968236091","https://openalex.org/W1969615558","https://openalex.org/W1977589132","https://openalex.org/W1979726443","https://openalex.org/W1983779046","https://openalex.org/W1985498707","https://openalex.org/W1985662452","https://openalex.org/W1986729011","https://openalex.org/W1988368267","https://openalex.org/W1996489671","https://openalex.org/W1999249353","https://openalex.org/W2007793016","https://openalex.org/W2008591744","https://openalex.org/W2009789534","https://openalex.org/W2010295821","https://openalex.org/W2012768600","https://openalex.org/W2013068857","https://openalex.org/W2014263310","https://openalex.org/W2017572390","https://openalex.org/W2019766936","https://openalex.org/W2020292843","https://openalex.org/W2021025717","https://openalex.org/W2022937460","https://openalex.org/W2024369575","https://openalex.org/W2028757060","https://openalex.org/W2031848004","https://openalex.org/W2033316662","https://openalex.org/W2033485870","https://openalex.org/W2033673890","https://openalex.org/W2034074758","https://openalex.org/W2034728834","https://openalex.org/W2035881418","https://openalex.org/W2039896702","https://openalex.org/W2046529500","https://openalex.org/W2051297635","https://openalex.org/W2051462052","https://openalex.org/W2055544593","https://openalex.org/W2058514432","https://openalex.org/W2061610222","https://openalex.org/W2066012664","https://openalex.org/W2066816981","https://openalex.org/W2067838047","https://openalex.org/W2068291692","https://openalex.org/W2071063977","https://openalex.org/W2076494499","https://openalex.org/W2085198637","https://openalex.org/W2085365282","https://openalex.org/W2087025850","https://openalex.org/W2103075451","https://openalex.org/W2110056344","https://openalex.org/W2112981414","https://openalex.org/W2113072178","https://openalex.org/W2114976181","https://openalex.org/W2115034481","https://openalex.org/W2115385656","https://openalex.org/W2117410359","https://openalex.org/W2118007770","https://openalex.org/W2130103830","https://openalex.org/W2131728483","https://openalex.org/W2132806782","https://openalex.org/W2135719046","https://openalex.org/W2139830508","https://openalex.org/W2147779427","https://openalex.org/W2150359377","https://openalex.org/W2150464859","https://openalex.org/W2150849997","https://openalex.org/W2152600766","https://openalex.org/W2164118512","https://openalex.org/W2165532973","https://openalex.org/W2166139086","https://openalex.org/W2287898190","https://openalex.org/W2314597781","https://openalex.org/W2334962709","https://openalex.org/W2467775914","https://openalex.org/W2474039479","https://openalex.org/W2979917648","https://openalex.org/W2980270105","https://openalex.org/W3180361994","https://openalex.org/W4211117577","https://openalex.org/W6928698941"],"related_works":["https://openalex.org/W2171947907","https://openalex.org/W2024369575","https://openalex.org/W2980665336","https://openalex.org/W2024816932","https://openalex.org/W2066723711","https://openalex.org/W2318389088","https://openalex.org/W1566154831","https://openalex.org/W1998535017","https://openalex.org/W2169683641"],"abstract_inverted_index":{"Introduksjon:":[0],"Nyretransplanterte":[1],"pasienter":[2,44,46,134,166,199,383],"er":[3,54,89,94,109,116,121,356],"i":[4,42,127,139,304,316,380],"stor":[5],"grad":[6],"utsatt":[7],"for":[8,29,183,207,220,225,230,290,347,376,388],"kardiovaskul\u00e6re":[9,125],"sykdommer":[10],"som":[11,58,93,180,384],"hypertensjon,":[12],"dyslipidemi,":[13],"endoteldysfunksjon":[14],"samt":[15,45,312],"nedsatt":[16],"glukosetoleranse":[17],"(IGT)/nyoppst\u00e5tt":[18],"diabetes":[19,41],"etter":[20,154,172,238],"transplantasjon":[21,262],"(NODAT).":[22],"Disse":[23],"pasientene":[24,282],"har":[25,386],"en":[26,50,55,140,301,313],"h\u00f8yere":[27],"risiko":[28],"prematur":[30],"kardiovaskul\u00e6r":[31,348],"sykdom":[32],"og":[33,68,83,87,131,156,177,198,211,227,237,255,258,286,307,319,329,371],"d\u00f8d":[34],"enn":[35,169],"den":[36,357],"generelle":[37],"populasjonen.":[38],"Behandling":[39],"av":[40,63,77,110,147,209,222,232,270,281,292,322,340,378],"nyretransplanterte":[43,165,364],"med":[47,123,135,150,174,188,244,276],"nyresvikt":[48],"representerer":[49,372],"utfordring.":[51],"Sitagliptin":[52,79],"(Januvia\u00ae)":[53],"dipeptidylpeptidase-4-hemmer":[56],"(DPP-4-hemmer)":[57],"\u00f8ker":[59],"de":[60],"systemiske":[61,119],"niv\u00e5ene":[62],"inkretinhormonene":[64],"glukagonlignende":[65],"peptid-1":[66],"(GLP-1)":[67],"glukoseavhengig":[69],"insulinotropt":[70],"peptid":[71],"(GIP),":[72],"siden":[73,261],"disse":[74],"hormonene":[75],"hydrolyseres":[76],"DPP-4.":[78],"stimulerer":[80],"dermed":[81],"insulinsekresjon":[82,210,223,318],"hemmer":[84],"glukagonfrigj\u00f8ring":[85],"indirekte,":[86],"dette":[88],"to":[90,287],"sentrale":[91],"mekanismer":[92],"svekket":[95],"ved":[96,248,310],"IGT/NODAT.":[97],"Nylig":[98],"forskning":[99],"indikerer":[100],"at":[101,118,325],"sitagliptin":[102,326,341,361],"ogs\u00e5":[103],"reduserer":[104],"inflammasjonsresponser":[105],"in":[106],"vitro.":[107],"Dette":[108,355],"potensiell":[111],"interesse,":[112],"da":[113],"det":[114,299],"tidligere":[115],"vist":[117],"inflammasjonsmark\u00f8rer":[120],"assosiert":[122],"negative":[124],"effekter":[126,339],"transplanterte":[128],"pasienter.\\n":[129],"\\nMaterialer":[130],"metoder:":[132],"25":[133,194],"IGT/NODAT":[136],"ble":[137,202,234,242,298,353],"inkludert":[138],"prospektiv,":[141],"\u00e5pen,":[142],"randomisert,":[143],"kontrollert,":[144],"kryss-over-studie":[145],"best\u00e5ende":[146],"fire":[148,157],"uker":[149,158],"sitagliptinbehandling":[151,297],"(dose":[152],"justert":[153,224],"nyrefunksjon)":[155],"uten":[159],"behandling":[160,291,377],"(kontrollperiode).":[161],"Hovedinklusjonskriteriene":[162],"var":[163,250,263,367],"voksne":[164],"fulgt":[167],"mer":[168],"ett":[170],"\u00e5r":[171,252],"transplantasjon,":[173],"stabil":[175,178],"nyrefunksjon":[176,226],"prednisolondose,":[179],"hadde":[181],"behov":[182,387],"(ekstra)":[184],"antidiabetisk":[185],"behandling.":[186],"Pasienter":[187],"alvorlig":[189],"leversykdom,":[190],"estimert":[191],"GFR":[192],"<":[193],"mL/min/1,73":[195],"m2,":[196],"gravide":[197],"p\u00e5":[200,284,288,343,363],"insulinbehandling":[201],"ekskludert.":[203],"Oral":[204],"glukosetoleransetest":[205],"(OGTT)":[206],"estimering":[208,221],"\u2013":[212],"sensitivitet,":[213],"C-peptid":[214],"til":[215],"glukose,":[216],"kreatinin":[217],"ratio":[218],"(CPGCR)":[219],"Laser-Doppler":[228],"flowmetri":[229],"bestemmelse":[231],"endotelfunksjon,":[233],"utf\u00f8rt":[235],"f\u00f8r":[236,294],"hver":[239],"studieperiode.":[240],"Inflammasjonsmark\u00f8rer":[241],"analysert":[243],"ELISA-kit.\\n":[245],"\\nResultater:":[246],"Gjennomsnittsalderen":[247],"inklusjon":[249],"63,6+/-10,9":[251],"(16":[253],"menn":[254],"9":[256],"kvinner),":[257],"gjennomsnittlig":[259],"tid":[260],"3,5+/-5,3":[264],"\u00e5r.":[265],"Den":[266],"immunsuppressive":[267],"behandlingen":[268],"bestod":[269],"ciklosporin,":[271],"tacrolimus":[272],"eller":[273,345],"everolimus":[274],"sammen":[275],"prednisolon":[277],"og/eller":[278],"mykofenolat.":[279],"Fem":[280],"stod":[283],"glipizid":[285],"glimepirid":[289],"NODAT":[293,379],"inklusjon.":[295],"Etter":[296],"observert":[300],"signifikant":[302,314],"reduksjon":[303],"b\u00e5de":[305,317],"fastende":[306,328],"postprandial":[308,330],"blodglukose":[309,331],"OGTT":[311],"\u00f8kning":[315],"CPGCR.":[320],"Hjemmem\u00e5ling":[321],"blodsukker":[323],"viste":[324,336],"reduserte":[327],"gjennom":[332],"hele":[333],"d\u00f8gnet.":[334],"Studien":[335],"ikke":[337,385],"relevante":[338],"verken":[342],"endotelfunksjon":[344],"plasmamark\u00f8rer":[346],"risiko.":[349],"Ingen":[350],"alvorlige":[351],"bivirkninger":[352],"observert.\\n\\nKonklusjon:":[354],"f\u00f8rste":[358],"studien":[359],"hvor":[360],"utpr\u00f8ves":[362],"pasienter.":[365],"Medikamentet":[366],"generelt":[368],"godt":[369],"tolerert":[370],"et":[373],"verdifullt":[374],"alternativ":[375],"denne":[381],"type":[382],"insulinbehandling.":[389]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2466833405","counts_by_year":[],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-07-22T00:00:00"}
